L2-01

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameL2-01

Drug Alias NameAdipose-derived mesenchymal stem cells (MSC) therapy (L2 Bio)L2-01

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesL2 Bio LLC

China Registration ClassN/A

Develop Information

Active CompaniesL2 Bio LLC

Inactive CompaniesN/A

Active IndicationsCrohn Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A